title: Risk of urinary tract infection after detrusor botulinum toxin A injections for refractory neurogenic detrusor overactivity in patients with no antibiotic treatment.
authors: Maya A
authors: MA
authors: Harris
authors: Chris
authors: C
authors: Harding
authors: Simon
authors: S
authors: Fulford
authors: Janet
authors: J
authors: Whiteway
mesh_terms: D019072:Antibiotic Prophylaxis; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D006801:Humans; D007273:Injections, Intramuscular; D009465:Neuromuscular Agents / Q000627:therapeutic use*; D012008:Recurrence; D012307:Risk Factors; D016896:Treatment Outcome; D001750:Urinary Bladder, Neurogenic / Q000188:drug therapy*; D053201:Urinary Bladder, Overactive / Q000188:drug therapy*; D014552:Urinary Tract Infections / Q000517:prevention & control*
chemical_list: D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A